Dilek Gogas Yavuz, Ceyda D Yazan, Zeliha Hekimsoy, Kadriye Aydin, Naile Gokkaya, Canan Ersoy, Aysen Akalın, Omercan Topaloglu, Berna I Aydogan, Esra N A Dilekci, Ziynet Alphan Uc, Guven B Cansu, Levent Ozsari, Ozlem T Iyidir, Mehtap E Olgun, Lezzan Keskin, Meral Mert, Bulent Can, Kaan Gungor, Tayfun Galip, Zeynep Cantürk, Gulsah Elbuken, Zafer Pekkolay, Nilufer O Kutbay, Goknur Yorulmaz, Ahmet T Kalkan, Yasemin A Unsal, Adnan Yay, Baris Karagun, Evin Bozkur
OBJECTIVE: Thyroid-stimulating hormone (TSH) suppression treatment can induce signs and symptoms of hyperthyroidism and hypothyroidism due to inappropriate treatment or poor compliance to the treatment. The current study aimed to investigate TSH levels, frequency of being on target TSH, adherence to levothyroxine (LT4) suppression treatment in differentiated thyroid cancer (DTC) patients after surgery in a multicentric setting. DESIGN AND PATIENTS: This multicentric cross-sectional study was conducted at 21 medical centres from 12 cities in Turkey...
May 31, 2022: Clinical Endocrinology